Frame
Frame
Frame
Frame
ONLINE ABSTRACT SUBMISSION
IMPORTANT DEADLINES
SEARCH
SOCIAL MEDIA
Frame Frame
Subscribe for Updates
OFFICIAL CARRIER
Frame
0137360

About Turkish Association of Psychopharmacology

 

The Turkish Association for Psychopharmacology (TAP) established in 2005, is the nation’s premier professional society in brain and psychopharmacology research. TAP’s core purpose is to advance scientific understanding of mental illnesses and to facilitate the communication and collaboration between convergent disciplines such as pre-clinical, clinical, and pharmaceutical industry in the field of psychopharmacology. To achieve this goal, TAP arranges scientific meetings, fosters research and teaching, encourages publication of primary data research and provides guidance and information to the public on matters relevant to psychopharmacology.

TAP organizes multiple scientific meetings and symposia every year from basic research to pharmaceutical developments and clinical applications. In recent years, TAP has begun to produce a range of consensual statements on the treatment of clinical disorders as well as the investigation of psychopharmaceutical compounds.

Among other objectives of the TAP are; professional improvement of psychiatrists, neurologists and other scientists (physiologists, pharmacologists, geneticists, etc.) who share a common interest in psychopharmacology, to establish standards of psychopharmacology education (for medical school students, psychiatry and other residents) and to operate at the highest level in conduct of this training, also to represent the psychopharmacology field in the commissions held by the Turkish Medical Association and Ministry of Health, and to share expert opinion in such meetings as well.

TAP encourages primary data research in the field of psychiatry and psychopharmacology, funds researchers, ensures the quality of the research and disseminates relevant advances in the field with its publications (mainly with in the Bulletin of Clinical Psychopharmacology and Journal of Mood Disorders). The TAP is committed to provide the best information available to mental health professionals, as well as to patients and patient representative groups.

TAP is committed to open dialogues with other scientific associations, foundations, unions, and also non-governmental organizations to establish a common platform in psychophramacology and related fields.

 

 The Bulletin of Clinical Psychopharmacology is indexed and abstracted in SCI-E (Science Citation Index- Expanded), EMBASE (Excerpta Medica), PsychINFO/Psychological Abstracts, PsycSCAN: Psychopharmacology, Curent Awareness in Biological Sciences (CABS), Chemical Abstracts(CAS), Elsevier BIOBASE, International Pharmaceutical Abstracts (IPA), Index Copernicus, Thomson Master Journal List, EBSCO host Current Abstracts, EbscoHost TOC premie, ProQuest Health & Medical Complete , ProQuest Psychology, DOAJ, British Library Direct, Scopus, Scopemed ve Turkish Citation Index, Turkish Psychiatry Index and Tubitak Tip Dizini, also as a printed material its being distributed to most universitiy libraries and related colleagues in Turkey. Also its being distributed online and as an interactive material to most international institutes and related professionals, free of charge.

 

  Journal of Mood Disorders is a publication of Turkish Associaton for Psychopharmacology Mood Disorders Section (TAP-MooDS). Journal is focused on bipolar, unipolar mood disorders and anxiety disorders.

 

 

 

TAP's activities include;

 1. ICP (14-17 December 2005) 
 2. ICP (22-24 June 2007)
 3. ICP (12-15 March 2009) 
 4. ICP (23-27 November 2011) 
 5. ICP (30 Oct. - 3 Nov. 2013) 
TU 2008 (29-31 January 2008) 
TU 2010 (11-14 March 2010) 
TU 2012 (15-18 November 2012)